Jane Street’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ORMP
GIA
BCM
Jane Street's ORMP Position: Q3 2026 in Review
Jane Street reduced its Oramed Pharmaceuticals (ORMP) stake by 76% in Q3 2026, selling an estimated $390K and leaving 27,068 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #10434.
Jane Street first reported a position in ORMP in Q1 2014 and has held it in 29 quarters since. The position peaked at $1.6M in Q4 2022. 93 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.
- Jane Street held 27,068 shares of Oramed Pharmaceuticals worth $126K as of Q3 2026.
- Jane Street sold 86,281 Oramed Pharmaceuticals shares in Q3 2026, an estimated $390K.
- Oramed Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10434 holding.
- Jane Street first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 29 quarters since.
- Jane Street's Oramed Pharmaceuticals position peaked at $1.6M in Q4 2022.
- 93 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.